Henk B. Luiting
Papers
1
Total Citations
5
H-Index
1
About
Henk B. Luiting is a urologic oncologist whose research centers on improving the detection and management of recurrent prostate cancer, with a particular focus on advanced imaging and salvage therapies. His major contributions lie in evaluating the clinical utility of Prostate Specific Membrane Antigen (PSMA) PET/CT for guiding treatment decisions after radical prostatectomy. In his most cited work, Luiting and colleagues assessed how PSMA PET/CT can predict short-term oncologic outcomes in patients undergoing salvage radiation therapy for biochemical recurrence, helping to identify those most likely to benefit from this approach. Though his citation counts are still growing, his work is already shaping how clinicians use molecular imaging to personalize salvage treatment strategies. Luiting’s research bridges the gap between cutting-edge imaging technology and practical patient care, offering clearer pathways for men facing rising PSA levels after surgery. His findings underscore the importance of accurate restaging in the era of precision oncology, and his ongoing investigations continue to refine the role of PSMA-targeted imaging in prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1